Chinese tighten stem cell regulation
But will they be enforced?
The Chinese Ministry
of Health is tightening up regulation of stem cell cures. People are
coming from all over the world to China for unproven stem cell
therapies offered by as many as 150 hospitals. Failures could damage
the reputation of the whole field. The Ministry has now classified all
stem cell therapies as “category 3” medical technologies —
those deemed "ethically problematic", "high risk"
or "still in need of clinical verification".
Although the
penalties for flouting these rules have not been published yet, offenders
will probably be fined or have their license to practice medicine
revoked. But in China, evading regulations is an art form. Some
researchers worry that hospitals will slither around the regulations
by labelling therapies as research, even if they are charging
patients and not carrying out the rigorous monitoring required by
clinical-trial protocols. ~ Nature, May 13
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...